Qualitest Recalls Acetaminophen and Codeine Oral Solution Due to Impurity
Qualitest Pharmaceuticals is recalling specific lots of Acetaminophen and Codeine Phosphate Oral Solution because they failed impurity specifications for p-Aminophenol.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class III, which indicates a low probability of adverse health consequences, aligning with the 'Moderate' severity score for minor labeling or low-risk contamination issues.
Plain-English summary
Qualitest Pharmaceuticals is voluntarily recalling specific lots of Acetaminophen and Codeine Phosphate Oral Solution USP, 120 mg/12 mg per 5 mL. The product is available in 4 oz (120 mL) bottles and one pint (473 mL) bottles. The recall affects nationwide distribution.
The recall was initiated because the product failed impurities and degradation specifications. Specifically, the known impurity p-Aminophenol resulted in high out-of-specification levels. The affected lots include L140H13B, L001D14A, L140H13A, L205K13A, L019L13A, L020L13A, L001D14B, and L091D14A, with expiration dates ranging from 03/15 to 10/15.
Consumers and healthcare providers should check their inventory for the specific NDCs (0603-9013-54 and 0603-9013-58) and lot numbers listed above. If the product matches the recalled lots, it should be discontinued and returned to the supplier or disposed of according to local regulations.
The recalled product
- Product
- ACETAMINOPHEN and CODEINE PHOSPHATE ORAL SOLUTION USP, 120 mg/12 mg per 5 mL, packaged in a) 4 oz. (120 mL) bottles, NDC 0603-9013-54, UPC 3 0603-9013-54 8 and b) ONE PINT (473 mL) bottles, NDC 0603-9013-58, UPC 3 0603-9013-58 6, Rx only, Manufactured for: QUALITEST PHARMACEUTICA
- Manufacturer
- Qualitest Pharmaceuticals
- Category
- Drug — Oral Solution
- Hazard
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (13)
- Lot #: a) L140H13B
- Exp. 03/15
- L001D14A. Exp. 08/15
- b) L140H13A
- L205K13A
- Exp. 05/15
- L019L13A
- L020L13A
- Exp. 06/15
- L001D14B
- 08/15
- L091D14A
- Exp. 10/15
Distribution
Distributed nationwide across the United States.
Related recalls
Same manufacturer · Qualitest Pharmaceuticals
See all →- LowQualitest Recalls Allopurinol Tablets Due to Oversized and Discolored Appearance
FDA (Drugs) · 2015-09-09
- LowQualitest Recalls HydrOXYzine Tablets Due to Unreadable Identification Codes
FDA (Drugs) · 2015-07-22
- ModerateQualitest Recalls Disulfiram Tablets Due to Dissolution Failure
FDA (Drugs) · 2015-07-08
- LowQualitest Recalls Promethazine VC With Codeine Syrup Due to Impurity
FDA (Drugs) · 2015-04-15
- ModerateQualitest Recalls Promethazine DM Syrup Due to Plastic Particulates
FDA (Drugs) · 2015-03-18
Same hazard · impurity
See all →- ModerateHikma Recalls Ramipril Capsules Due to Process Impurity
FDA (Drugs) · 2026-09-02
- ModerateMedline Remedy Specialized Silicone Cream Recalled for Elevated Formaldehyde Levels
FDA (Drugs) · 2026-07-15
- SevereCinacalcet Hydrochloride Tablets Recalled for Elevated Impurity Levels
FDA (Drugs) · 2026-07-08
- HighDuloxetine 30mg delayed-release capsules exceed nitrosamine impurity interim limit
FDA (Drugs) · 2026-06-17
- HighDuloxetine 60mg delayed-release capsules exceed nitrosamine impurity interim limit
FDA (Drugs) · 2026-06-17